These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Immunosuppression enhances atherogenicity of lipid profile after transplantation. Quaschning T; Mainka T; Nauck M; Rump LC; Wanner C; Krämer-Guth A Kidney Int Suppl; 1999 Jul; 71():S235-7. PubMed ID: 10412786 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein levels and post-heparin lipase activities in kidney transplant recipients: ciclosporin- versus non-ciclosporin-treated patients. Arnadottir M; Thysell H; Nilsson-Ehle P Am J Nephrol; 1991; 11(5):391-6. PubMed ID: 1809036 [TBL] [Abstract][Full Text] [Related]
11. The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients. Hricik DE; Bartucci MR; Mayes JT; Schulak JA Transplantation; 1992 Nov; 54(5):868-71. PubMed ID: 1440855 [TBL] [Abstract][Full Text] [Related]
12. The effects of gender and type of diabetes on HDL-cholesterol. Merrin PK; Baynes C; Henderson A; Richmond B; Elkeles R Diabete Metab; 1994; 20(1):20-4. PubMed ID: 8056130 [TBL] [Abstract][Full Text] [Related]
13. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of a corticosteroid-free immunosuppressive regimen in recipients of pancreatic transplant. Luzi L; Picena Sereni L; Battezzati A; Elli A; Soulillou JP; Cantarovich D Transplantation; 2003 Jun; 75(12):2018-23. PubMed ID: 12829904 [TBL] [Abstract][Full Text] [Related]
15. Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor. Reitsma JB; Castro Cabezas M; de Bruin TW; Erkelens DW Metabolism; 1994 Mar; 43(3):293-8. PubMed ID: 8139476 [TBL] [Abstract][Full Text] [Related]
16. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975 [TBL] [Abstract][Full Text] [Related]
17. Metabolic risk factors for cardiovascular disease in pancreas and kidney transplant recipients. Nyberg G; Fager G; Mjörnstedt L; Olausson M Diabetologia; 1991 Aug; 34 Suppl 1():S44-6. PubMed ID: 1936693 [TBL] [Abstract][Full Text] [Related]
18. Renal function and lipid metabolism in pregnant renal transplant recipients. Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508 [TBL] [Abstract][Full Text] [Related]
19. High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. Patsch JR; Prasad S; Gotto AM; Patsch W J Clin Invest; 1987 Aug; 80(2):341-7. PubMed ID: 3611351 [TBL] [Abstract][Full Text] [Related]
20. Lipid status after pancreas-kidney transplantation. Larsen JL; Stratta RJ; Ozaki CF; Taylor RJ; Miller SA; Duckworth WC Diabetes Care; 1992 Jan; 15(1):35-42. PubMed ID: 1737540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]